Description
Daunorubicin and Cytarabine, marketed under the brand name VYXEOS, It is an prescription medication that has been approved the combination of daunorubicin and cytarabine, also known as Vyxeos (CPX-351), on August 3, 2017. This liposomal formulation is used to treat adults with newly diagnosed therapy-related acute myeloid leukemia (t-AML) or acute myeloid leukemia (AML) with myelodysplasia-related changes (AML-MRC).
What is VYXEOS (daunorubicin and cytarabine) ?
VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor, that is indicated for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).
How to order approved “VYXEOS (daunorubicin and cytarabine) for injection” Medicine?
VYXEOS (Daunorubicin and Cytarabine) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing VYXEOS and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
